
Upcoming FDA-AACR-ASA Workshop to Examine Overall Survival in Oncology Clinical Trials
When faced with a cancer diagnosis, patients often find themselves asking, “How long will I live? Which treatments will...
When faced with a cancer diagnosis, patients often find themselves asking, “How long will I live? Which treatments will...
The milieu of cells, proteins, and vasculature that comprise the tumor microenvironment can hinder efforts to treat cancer. This...
“Where is the field of cancer research going?” posed Robert Vonderheide, MD, DPhil, as he welcomed attendees to “AACR...
“Are you ready to have a great meeting?” Robert Vonderheide, MD, DPhil, asked the nearly 11,000 attendees gathered in...
The 2015 approval of an immune checkpoint inhibitor for renal cell carcinoma (RCC) provided a much-needed new treatment option...
The plenary program of the AACR Annual Meeting 2023 kicked off Saturday, April 15, with a session titled “Beating...
Outside the lab, Frank McCormick, PhD, FAACR, is a racecar driver, nurturing a passion he developed decades ago. (“We...
By producing and storing bile, the collection of organs that comprise the biliary tract are important contributors to digestion....
Cancer treatment is a double-edged sword. Intense or multi-pronged treatment may lead to better killing of tumor cells, but...
Researchers, physicians, patients, and other stakeholders convened in San Antonio, Texas, December 6-10 for the annual San Antonio Breast...